On Monday, Lilly(Eli) & Co (NYSE: LLY) opened lower -3.60% from the last session, before settling in for the closing price of $1080.36. Price fluctuations for LLY have ranged from $623.78 to $1111.99 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 18.77%. Company’s average yearly earnings per share was noted 82.84% at the time writing. With a float of $851.26 million, this company’s outstanding shares have now reached $945.84 million.
Lilly(Eli) & Co (LLY) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Lilly(Eli) & Co is 9.96%, while institutional ownership is 73.21%. The most recent insider transaction that took place on Dec 29 ’25, was worth 3,898,531. In this transaction 10% Owner of this company sold 3,593 shares at a rate of $1085.04, taking the stock ownership to the 92,190,516 shares. Before that another transaction happened on Dec 24 ’25, when Company’s 10% Owner sold 2,629 for $1085.17, making the entire transaction worth $2,852,920. This insider now owns 92,194,109 shares in total.
Lilly(Eli) & Co (LLY) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 5.32 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 5.07) by 0.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of 7.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 82.84% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.53% during the next five years compared to 18.77% growth over the previous five years of trading.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
Check out the current performance indicators for Lilly(Eli) & Co (LLY). In the past quarter, the stock posted a quick ratio of 1.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.57. Likewise, its price to free cash flow for the trailing twelve months is 106.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 20.22, a number that is poised to hit 7.20 in the next quarter and is forecasted to reach 32.49 in one year’s time.
Technical Analysis of Lilly(Eli) & Co (LLY)
Compared to the last year’s volume of 3.28 million, its volume of 2.22 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 54.75%.
During the past 100 days, Lilly(Eli) & Co’s (LLY) raw stochastic average was set at 84.92%, which indicates a significant increase from 16.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 23.65 in the past 14 days, which was higher than the 23.08 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1,002.15, while its 200-day Moving Average is $829.08. Nevertheless, the first resistance level for the watch stands at $1,073.47 in the near term. At $1,105.42, the stock is likely to face the second major resistance level. The third major resistance level sits at $1,125.47. If the price goes on to break the first support level at $1,021.47, it is likely to go to the next support level at $1,001.42. Should the price break the second support level, the third support level stands at $969.47.
Lilly(Eli) & Co (NYSE: LLY) Key Stats
There are currently 945,384K shares outstanding in the company with a market cap of 984.63 billion. Presently, the company’s annual sales total 45,043 M according to its annual income of 10,590 M. Last quarter, the company’s sales amounted to 17,601 M and its income totaled 5,583 M.
